Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance New data expands on findings ...
Drug Delivery Business

Senseonics study supports Eversense 365 CGM with automated insulin delivery tech

Senseonics (NYSE:SENS) today announced real-world evidence supporting the performance of its Eversense 365 year-long CGM ...
Medscape

Closed-Loop Insulin System for T1D in Pregnancy

Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...
Nanowerk

Dual closed-loop insulin system adds chemical safeguard to protect against dangerous overdoses

A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced hypoglycemia from 4.01% to 0.52% in diabetic rats. (Nanowerk Spotlight) An ...